“…When making decisions about end‐of‐life care for people with dementia, surrogates presented uncertainty in the following areas: (a) patients' status, prognoses and disease trajectories (Dening et al., 2012; Fisher et al., 2022; Kelly et al., 2002; Kupeli et al., 2019; Kwak & Noh, 2018; Lopez & Guarino, 2011; Radcliffe et al., 2023; Van Rickstal et al., 2019), (b) end‐of‐life treatment options and their risks and benefits (Sodowsky, 2012; Stone & Jones, 2009; Truglio‐Londrigan & Slyer, 2019; Unson et al., 2015), (c) the right decisions about end‐of‐life care (Dening et al., 2012; Fetherstonhaugh et al., 2017, 2019; Kelly et al., 2002; Kupeli et al., 2019; Lopez & Guarino, 2011; Mezey et al., 1996; Unson et al., 2015), (d) patients' values, wishes and treatment preferences (Dening et al., 2016; Kwak & Noh, 2018; Lamahewa et al., 2018), (e) their roles and responsibilities as surrogate decision‐makers (Fetherstonhaugh et al., 2019; Lamahewa et al., 2018), (f) ways to make decisions (Fetherstonhaugh et al., 2017), and (g) emotional and practical preparation for a patient's death (Fisher et al., 2022). Figure 2 depicts surrogate uncertainty, including its antecedents, how surrogates process uncertainty, and the development of new life perspectives.…”